Gemini Therapeutics, Inc. /DE
Gemini Therapeutics, Inc. /DE (GMTX) is a publicly traded company in the Unknown sector. Across all available filings, 5 corporate insiders have executed 12 transactions totaling $1.6M, demonstrating a bullish sentiment with $1.5M in net insider flow. The most recent transaction on Oct 26, 2022 involved a sale of 22,500 shares valued at $47.0K.
GMTX Insider Activity Summary
Who Is Buying GMTX Stock?
No significant insider buying has been recorded for GMTX in the recent period.
Who Is Selling GMTX Stock?
No significant insider selling has been recorded for GMTX in the recent period.
Is Gemini Therapeutics, Inc. /DE Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for GMTX is bullish with an Insider Alignment Score of 97/100 and a net flow of $1.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
GMTX Frequently Asked Questions
Understanding GMTX Insider Activity
Insider trading at Gemini Therapeutics, Inc. /DE (GMTX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 5 insiders are actively trading GMTX stock, having executed 12 transactions in the past 90 days. The most active insider is Capital Opportunity Management V, Llc Foresite (Executive), who has made 2 transactions totaling $15.0M.
Related Tools
Track Gemini Therapeutics, Inc. /DE Insider Activity
Get notified when executives and directors at GMTX file new Form 4 transactions